603259 药明康德
已收盘 05-09 15:00:00
资讯
新帖
简况
每周股票复盘：药明康德（603259）大宗交易金额达985.35万元
证券之星 · 05-09 17:45
每周股票复盘：药明康德（603259）大宗交易金额达985.35万元
药明康德：公司一季度收入及利润均重回双位数增长
证券之星 · 05-09 09:30
药明康德：公司一季度收入及利润均重回双位数增长
药明康德：截至2025年3月31日公司非流动负债余额为28.59亿元包含长期借款租赁负债递延收益以及递延所得税负债
证券之星 · 05-09 09:30
药明康德：截至2025年3月31日公司非流动负债余额为28.59亿元包含长期借款租赁负债递延收益以及递延所得税负债
药明康德：公司已于2025年4月29日召开了股东大会
证券之星 · 05-09 09:30
药明康德：公司已于2025年4月29日召开了股东大会
药明康德：有关债券相关主要条款请见公司于2024年10月8日所披露的公告
证券之星 · 05-09 09:30
药明康德：有关债券相关主要条款请见公司于2024年10月8日所披露的公告
药明康德：公司已于2025年4月18日迅速启动了2025年第二次以集中竞价交易方式回购公司股份事项
证券之星 · 05-09 09:30
药明康德：公司已于2025年4月18日迅速启动了2025年第二次以集中竞价交易方式回购公司股份事项
A股董事长薪酬出炉！药明康德李革以4180万断层领跑，药企霸榜前三！
财中社 · 05-08
A股董事长薪酬出炉！药明康德李革以4180万断层领跑，药企霸榜前三！
港股午评：恒指收涨0.49% 军工股强势领涨
美港电讯 · 05-07
港股午评：恒指收涨0.49% 军工股强势领涨
药明康德大跌3% 券商看好增持
智选洞察 · 05-07
药明康德大跌3% 券商看好增持
药明康德：2025年4月全球生物医药领域累计公开披露融资总额超31亿美元
界面 · 05-06
药明康德：2025年4月全球生物医药领域累计公开披露融资总额超31亿美元
药明康德(603259.SH)累计回购285.59万股 耗资1.6亿元
智通财经 · 05-06
药明康德(603259.SH)累计回购285.59万股 耗资1.6亿元
中金：降药明康德目标价至78.8港元 维持“跑赢行业”评级
新浪港股 · 05-06
中金：降药明康德目标价至78.8港元 维持“跑赢行业”评级
药明康德(02359)累计回购约285.59万股A股
智通财经 · 05-06
药明康德(02359)累计回购约285.59万股A股
药明康德：累计回购约286万股
每日经济新闻 · 05-06
药明康德：累计回购约286万股
药明康德2024年度和2025特别分红总额调整为28.32亿元和10.098亿元
财中社 · 05-06
药明康德2024年度和2025特别分红总额调整为28.32亿元和10.098亿元
中金：降药明康德(02359)目标价至78.8港元 维持“跑赢行业”评级
智通财经 · 05-06
中金：降药明康德(02359)目标价至78.8港元 维持“跑赢行业”评级
港股异动 | CRO概念股早盘普跌 维亚生物(01873)跌超4% 药明康德(02359)跌超3%
智通财经 · 05-06
港股异动 | CRO概念股早盘普跌 维亚生物(01873)跌超4% 药明康德(02359)跌超3%
恒生生物科技指数午后持续扩大升幅，药明康德(02359.HK)涨近8%，药明生物(02269.HK)涨超6%。
美港电讯 · 05-02
恒生生物科技指数午后持续扩大升幅，药明康德(02359.HK)涨近8%，药明生物(02269.HK)涨超6%。
恒生生物科技指数盘中涨超1% 药明康德领涨
DoNews · 05-02
恒生生物科技指数盘中涨超1% 药明康德领涨
港股异动 | 药明康德(02359)再涨超5% 一季度净利增超89% 高盛称公司有空间在下半年提高指引
智通财经 · 05-02
港股异动 | 药明康德(02359)再涨超5% 一季度净利增超89% 高盛称公司有空间在下半年提高指引
加载更多
公司概况
公司名称：
无锡药明康德新药开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2018-05-08
主营业务：
无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务。
发行价格：
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":59.06,"timestamp":1746774000000,"preClose":58.98,"halted":0,"volume":24089989,"delay":0,"changeRate":0.0014,"floatShares":2501000000,"shares":2888000000,"eps":3.8713,"marketStatus":"已收盘","change":0.08,"latestTime":"05-09 15:00:00","open":58.8,"high":59.39,"low":58.48,"amount":1421000000,"amplitude":0.0154,"askPrice":59.06,"askSize":76,"bidPrice":59.05,"bidSize":1083,"shortable":0,"etf":0,"ttmEps":3.8713,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":58.98,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":64.88,"lowLimit":53.08,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2887992582,"isCdr":false,"pbRate":2.74,"roa":"--","peRate":15.255857,"roe":"6.08%","epsLYR":3.28,"committee":0.285418,"marketValue":170565000000,"turnoverRate":0.0096,"status":0,"hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":61.1,"timestamp":1746778087031,"preClose":61.5,"halted":0,"volume":3651587,"delay":0,"premium":"-3.70"},"floatMarketCap":147704000000},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2534459849","title":"每周股票复盘：药明康德（603259）大宗交易金额达985.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534459849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534459849?lang=zh_cn&edition=full","pubTime":"2025-05-10 01:45","pubTimestamp":1746812714,"startTime":"0","endTime":"0","summary":"截至2025年5月9日收盘，药明康德（603259）报收于59.06元，较上周的59.17元下跌0.19%。本周，药明康德5月7日盘中最高价报61.4元。5月7日盘中最低价报57.92元。药明康德当前最新总市值1705.65亿元，在医疗服务板块市值排名1/50，在两市A股市值排名70/5145。本周关注点交易信息汇总: 5月7日药明康德现985.35万元大宗交易交易信息汇总5月7日，药明康德发生了985.35万元的大宗交易。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051000001355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1046422090.SGD","LU1997245177.USD","BK1141","LU1997245094.SGD","LU2488822045.USD","LU2242644610.SGD","BK0216","02359","LU2045819591.USD","LU2495084118.USD","BK1583","LU0456842615.SGD","LU0052750758.USD","LU0320764599.SGD","LU1997244956.HKD","LU0708995583.HKD","LU2328871848.SGD","LU2125910500.SGD","LU1969619763.USD","BK1576","603259"],"gpt_icon":0},{"id":"2534284171","title":"药明康德：公司一季度收入及利润均重回双位数增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2534284171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534284171?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:30","pubTimestamp":1746783046,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德(603259)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：建议公司积极响应国家号召，提前自愿披露一季度业绩预告药明康德回复：您好，感谢您对公司的关注。公司已于4月29日披露2025年第一季度报告。公司一季度收入及利润均重回双位数增长，收入同比增长21.0%，经调整Non-IFRS归母净利润同比增长40.0%，持续经营业务在手订单同比增长47.1%。具体内容请见公司于2025年4月29日披露的《2025年第一季度报告》。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900027755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU1997245177.USD","LU2045819591.USD","LU1969619763.USD","LU2242644610.SGD","LU2125910500.SGD","LU2328871848.SGD","LU0052750758.USD","BK0216","LU0456842615.SGD","02359","LU2495084118.USD","BK1576","LU1997245094.SGD","LU1046422090.SGD","LU2488822045.USD","603259","LU1997244956.HKD","LU0708995583.HKD","LU0320764599.SGD","BK1141"],"gpt_icon":0},{"id":"2534171444","title":"药明康德：截至2025年3月31日公司非流动负债余额为28.59亿元包含长期借款租赁负债递延收益以及递延所得税负债","url":"https://stock-news.laohu8.com/highlight/detail?id=2534171444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534171444?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:30","pubTimestamp":1746783044,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德(603259)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问2025年一季报里流动负债里面有一栏叫非流动负债有35.13亿，具体是哪些负债构成的？药明康德回复：您好，感谢您对公司的关注。截至2025年3月31日，公司非流动负债余额为28.59亿元，包含长期借款、租赁负债、递延收益以及递延所得税负债；公司其他流动负债余额为35.13亿元，主要为公司发行的可转债。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900027746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2328871848.SGD","02359","BK1583","BK1141","LU2242644610.SGD","LU2125910500.SGD","LU2488822045.USD","LU1997245094.SGD","603259","LU0708995583.HKD","LU2045819591.USD","BK0216","LU0052750758.USD","LU0320764599.SGD","LU1046422090.SGD","LU2495084118.USD","LU1997245177.USD","LU0456842615.SGD","LU1997244956.HKD","BK1576","LU1969619763.USD"],"gpt_icon":0},{"id":"2534171115","title":"药明康德：公司已于2025年4月29日召开了股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2534171115","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534171115?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:30","pubTimestamp":1746783044,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德(603259)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：你们近期要开股东大会么，从哪里进入药明康德回复：您好，感谢您对公司的关注。公司已于2025年4月29日召开了股东大会，具体情况可见公司于2025年4月30日披露的《2024年度股东大会、2025年第一次A股类别股东会议及2025年第一次H股类别股东会议决议公告》。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900027744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245177.USD","02359","LU1997245094.SGD","LU0052750758.USD","LU0456842615.SGD","LU2488822045.USD","LU2495084118.USD","LU2125910500.SGD","LU1046422090.SGD","LU1969619763.USD","BK1141","BK1576","BK0216","LU2242644610.SGD","LU0708995583.HKD","LU2045819591.USD","LU2328871848.SGD","LU0320764599.SGD","LU1997244956.HKD","603259","BK1583"],"gpt_icon":0},{"id":"2534171287","title":"药明康德：有关债券相关主要条款请见公司于2024年10月8日所披露的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2534171287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534171287?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:30","pubTimestamp":1746783043,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司24年10月底发行了5亿美元、0利率的可转债，初始转股价为80.02港元，请问是否意味着到25年10月前，港股估计超过80港币，对公司、认购方和原始股东三方是最有利的？有关债券相关主要条款请见公司于2024年10月8日所披露的《关于拟发行5亿美元于2025年到期之零息有担保可转换债券的公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900027745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245177.USD","02359","LU0052750758.USD","LU0708995583.HKD","BK0216","LU2328871848.SGD","LU2045819591.USD","BK1141","603259","LU1969619763.USD","BK1576","LU0456842615.SGD","LU1997245094.SGD","LU2495084118.USD","LU2488822045.USD","LU2242644610.SGD","LU1046422090.SGD","BK1583","LU2125910500.SGD","LU1997244956.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2534017141","title":"药明康德：公司已于2025年4月18日迅速启动了2025年第二次以集中竞价交易方式回购公司股份事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2534017141","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534017141?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:30","pubTimestamp":1746783043,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德(603259)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司第二次回购方案，何时可以开始实施？是否需要等到银行回购专项贷款到位后才有钱购买药明康德回复：您好，感谢您对公司的关注。公司已于2025年4月18日迅速启动了2025年第二次以集中竞价交易方式回购公司股份事项，进展情况可参见公司于2025年4月19日、2025年5月7日披露的有关公告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900027742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997244956.HKD","02359","LU1969619763.USD","LU2045819591.USD","BK1576","LU1997245177.USD","LU0708995583.HKD","LU0052750758.USD","LU0320764599.SGD","603259","LU1046422090.SGD","LU2125910500.SGD","LU2495084118.USD","LU0456842615.SGD","LU2328871848.SGD","LU2242644610.SGD","LU2488822045.USD","BK1583","LU1997245094.SGD","BK0216","BK1141"],"gpt_icon":0},{"id":"2533054619","title":"A股董事长薪酬出炉！药明康德李革以4180万断层领跑，药企霸榜前三！","url":"https://stock-news.laohu8.com/highlight/detail?id=2533054619","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533054619?lang=zh_cn&edition=full","pubTime":"2025-05-08 17:15","pubTimestamp":1746695723,"startTime":"0","endTime":"0","summary":"2024年A股董事长薪酬TOP20榜单正式揭晓，药明康德董事长李革以4180万元年薪“一骑绝尘”，成为A股市场唯一薪酬突破4000万元的董事长，较第二名迈瑞医疗李西廷的2494万元高出近七成，堪称“断层式领跑”。不过，部分企业董事长“天价薪酬”与股价表现的分化亦引发讨论，例如百济神州虽连年亏损，但其董事长薪酬仍高居第三。药明康德李革以4180万断层领跑，药企霸榜前三！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173016a6d77036&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173016a6d77036&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245177.USD","LU1997245094.SGD","399300","LU1969619763.USD","LU0456842615.SGD","159982","LU1997244956.HKD","LU2495084118.USD","603259","LU2328871848.SGD","LU2488822045.USD","BK0216"],"gpt_icon":0},{"id":"2533587644","title":"港股午评：恒指收涨0.49% 军工股强势领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2533587644","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533587644?lang=zh_cn&edition=full","pubTime":"2025-05-07 12:10","pubTimestamp":1746591013,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["00285","09660","LU0823038988.USD","161726","BK1193","LU0164865239.USD","TME","09961","09939","YANG","HXXD.SI","LU0011963245.USD","MCHmain","LU0561508036.HKD","02269","513600","159938","LU0499858438.USD","SG9999001903.USD","IE00B3M56506.USD","02359","MHImain","LU0488056044.USD","TCOM","BK1515","LU1242518931.SGD","LU0348735423.USD","07226","XIACY","HSTECH","BK1521","LU0348767384.USD","399441","HHImain","BK4571","81810","HSI","01698","01810","161024","603259","00881","HSCEI","LU2097828714.EUR","BK4548","BK1587","02833","HSImain"],"gpt_icon":0},{"id":"2533617699","title":"药明康德大跌3% 券商看好增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2533617699","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533617699?lang=zh_cn&edition=full","pubTime":"2025-05-07 10:14","pubTimestamp":1746584055,"startTime":"0","endTime":"0","summary":"05月07日，药明康德股价大幅下跌，截至10点14分，药明康德下跌3.00%，报58.53元/股，失守60元整数关口，成交16.85亿元，换手率1.14%。资金动向截止发稿，药明康德获得主力净流出1.86亿元，其中超大单流出2.14亿元，大单流入2849万元。最新财报显示，今年一季报，药明康德实现营业收入96.55亿元，同比增长20.96%，净利润为36.72亿元，同比增长89.06%，基本每股收益为1.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507101421a6d5ba21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507101421a6d5ba21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU2495084118.USD","603259","LU1997245094.SGD","LU1997245177.USD","LU1997244956.HKD","BK0216","LU0456842615.SGD"],"gpt_icon":0},{"id":"2533769441","title":"药明康德：2025年4月全球生物医药领域累计公开披露融资总额超31亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533769441","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533769441?lang=zh_cn&edition=full","pubTime":"2025-05-07 07:42","pubTimestamp":1746574977,"startTime":"0","endTime":"0","summary":"根据药明康德数据库统计，截至2025年4月30日，2025年4月全球生物医药领域共计完成139起融资活动，累计公开披露的融资总额超过了31亿美元。其中，有20家专注于开发创新药的公司完成的单笔融资额突破了5000万美元大关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050707425797512be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050707425797512be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245094.SGD","LU2488822045.USD","603259","LU1997245177.USD","399441","LU0456842615.SGD","LU2495084118.USD","LU1997244956.HKD","161726","02359","BK0216"],"gpt_icon":0},{"id":"2533689287","title":"药明康德(603259.SH)累计回购285.59万股 耗资1.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533689287","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533689287?lang=zh_cn&edition=full","pubTime":"2025-05-06 19:14","pubTimestamp":1746530095,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(603259.SH)公告，截至2025年4月30日，公司累计通过集中竞价交易方式回购A股股份285.59万股，占公司本公告日总股本的0.0989%，回购最高价格人民币61.54元/股，回购最低价格人民币52.52元/股，使用资金总额人民币1.6亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","LU1997245177.USD","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD","LU0052750758.USD","BK0216","LU0456842615.SGD","LU2495084118.USD","02359","BK1576","LU1997245094.SGD","LU1046422090.SGD","LU2488822045.USD","603259","LU1997244956.HKD","LU0708995583.HKD","LU0320764599.SGD","BK1141"],"gpt_icon":0},{"id":"2533887846","title":"中金：降药明康德目标价至78.8港元 维持“跑赢行业”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2533887846","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533887846?lang=zh_cn&edition=full","pubTime":"2025-05-06 18:28","pubTimestamp":1746527280,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 中金发布研报称，药明康德（02359）2025年首季收入同比增21%至96.5亿元人民币；持续经营业务收入增23.1%至93.9亿；纯利增89.1%至36.72亿元；经调整non-IFRS纯利增40%至26.8亿元；持续经营业务在手订单增47.1%至523.3亿元，略超预期。中金称其订单增长强劲，Tides业务持续扩张，维持“跑赢行业”评级，但因行业系统性回调，H股目标价下调10.5%至78.8港元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-05-06/doc-inevrray2096121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","603259"],"gpt_icon":0},{"id":"2533050563","title":"药明康德(02359)累计回购约285.59万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533050563","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533050563?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:37","pubTimestamp":1746524262,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)公布2025 年第二次以集中竞价交易方式回购公司股份的进展，截至 2025 年 4 月 30 日，公司累计通过集中竞价交易方式回购A股股份2,855,916 股，占公司本公告日总股本的 0.0989%，回购最高价格人民币61.54元/ 股，回购最低价格人民币 52.52 元/股，使用资金总额人民币160,058,458.32 元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289649.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","399300","LU2125910500.SGD","603259","BK1583","BK1576","LU0708995583.HKD","LU1997244956.HKD","LU1997245094.SGD","159982","BK0216","LU2045819591.USD","LU0052750758.USD","LU2488822045.USD","LU0320764599.SGD","LU2495084118.USD","LU1046422090.SGD","BK1141","LU2242644610.SGD","LU1997245177.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2533505255","title":"药明康德：累计回购约286万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505255","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533505255?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:24","pubTimestamp":1746523442,"startTime":"0","endTime":"0","summary":"每经AI快讯，药明康德（SH 603259，收盘价：60.34元）5月6日晚间发布公告称，截至2025年4月30日，公司累计通过集中竞价交易方式回购A股股份约286万股，占公司本公告日总股本的0.0989%，回购最高价格人民币61.54元/股，回购最低价格人民币52.52元/股，使用资金总额人民币约1.6亿元。截至发稿，药明康德市值为1743亿元。每经头条（nbdtoutiao）——巴菲特对美元罕见“警告”后金价重拾升势！投资黄金股看似“避险+增长”双保险，实则暗藏五大真相！(记者 王晓波)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617255694edce19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617255694edce19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603259","LU2488822045.USD","LU2495084118.USD","LU1997244956.HKD","BK0216","LU1997245094.SGD","LU0456842615.SGD","LU1997245177.USD"],"gpt_icon":0},{"id":"2533505257","title":"药明康德2024年度和2025特别分红总额调整为28.32亿元和10.098亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505257","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533505257?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:20","pubTimestamp":1746523239,"startTime":"0","endTime":"0","summary":"5月6日，药明康德（603259/02359）发布公告，因公司实施了回购A股股份方案，导致公司享有利润分配权的总股本发生变动。公司按照维持每股分配金额不变的原则进行分配，相应调整分配总额。调整后2024年度利润分配方案分红总额为28.32亿元，2025年回报股东特别分红方案派发红利总额为10.098亿元。2025年一季度，药明康德实现收入96.55亿元，归母净利润36.72亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617211097507d34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617211097507d34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","LU1997245177.USD","603259","BK0216","LU0456842615.SGD","LU1997244956.HKD","LU1997245094.SGD","LU2495084118.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2533557629","title":"中金：降药明康德(02359)目标价至78.8港元 维持“跑赢行业”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2533557629","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533557629?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:14","pubTimestamp":1746519264,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，药明康德(02359)2025年首季收入同比增21%至96.5亿元人民币;持续经营业务收入增23.1%至93.9亿;纯利增89.1%至36.72亿元;经调整non-IFRS纯利增40%至26.8亿元;持续经营业务在手订单增47.1%至523.3亿元，略超预期。中金称其订单增长强劲，Tides业务持续扩张，维持“跑赢行业”评级，但因行业系统性回调，H股目标价下调10.5%至78.8港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","02359"],"gpt_icon":0},{"id":"2533551622","title":"港股异动 | CRO概念股早盘普跌 维亚生物(01873)跌超4% 药明康德(02359)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533551622","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533551622?lang=zh_cn&edition=full","pubTime":"2025-05-06 10:45","pubTimestamp":1746499512,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股早盘普跌，截至发稿，维亚生物跌4.58%，报1.46港元；药明康德跌3.03%，报62.45港元；康龙化成跌2.07%，报14.16港元；凯莱英跌0.52%，报57.05港元。消息面上，据报道，美国总统特朗普表示，他将在未来两周内宣布对医药产品的关税措施。但从产业链来看，国内医药外包服务公司已成为全球医药产业链重要一环，对美国大药企提升研发效率将更多精力聚焦于后端药品研发制造，实现医药工业生产及价值创造提供了支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","BK1583","01873","LU1997245177.USD","LU2045819591.USD","03759","LU2242644610.SGD","LU2125910500.SGD","LU0052750758.USD","BK1191","BK0216","LU0456842615.SGD","02359","LU2495084118.USD","BK1576","LU1997245094.SGD","LU1046422090.SGD","LU2488822045.USD","603259","LU1997244956.HKD","LU0708995583.HKD","LU0320764599.SGD","BK1141"],"gpt_icon":0},{"id":"2532645138","title":"恒生生物科技指数午后持续扩大升幅，药明康德(02359.HK)涨近8%，药明生物(02269.HK)涨超6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532645138","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532645138?lang=zh_cn&edition=full","pubTime":"2025-05-02 13:18","pubTimestamp":1746163100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999002562.SGD","LU0327786744.USD","LU1242518857.USD","LU0823426308.USD","LU2488822045.USD","LU1997245177.USD","IE00B0JY6N72.USD","SG9999002463.SGD","LU1997244956.HKD","LU0417516738.SGD","LU0516423174.USD","LU0326950275.SGD","02269","LU0140636845.USD","LU1794554557.SGD","LU0181495838.USD","LU0348825331.USD","LU2039709279.SGD","603259","LU0708995583.HKD","LU1997245094.SGD","BK1576","LU1242518931.SGD","LU2125910500.SGD","LU1720050803.USD","BK1589","LU0320764599.SGD","LU0588546209.SGD","LU1880383366.USD","LU0307460666.USD","LU0819121731.USD","LU0052750758.USD","LU0359202008.SGD","LU0456846285.SGD","LU0516422440.USD","LU2045819591.USD","LU0516423091.SGD","BK1521","LU0051755006.USD","BK1141","LU0856984785.SGD","LU0456842615.SGD","LU0417516902.SGD","02359","LU0456827905.SGD","BK0216","BK1583","LU0516422366.SGD","159892","LU2495084118.USD"],"gpt_icon":0},{"id":"2532317850","title":"恒生生物科技指数盘中涨超1% 药明康德领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2532317850","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532317850?lang=zh_cn&edition=full","pubTime":"2025-05-02 10:55","pubTimestamp":1746154502,"startTime":"0","endTime":"0","summary":"5月2日，恒生生物科技指数盘中涨幅超过1%。其中，药明康德涨超5%，成为领涨龙头。此外，药明生物、京东健康、信达生物等多只成分股也表现强势，推动指数上扬。市场分析认为，生物医药板块近期受到资金关注，行业前景被持续看好。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050210562594ea6324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050210562594ea6324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","LU2495084118.USD","LU0456842615.SGD","LU1997245094.SGD","603259","LU2488822045.USD","159892","LU1997245177.USD","LU1997244956.HKD"],"gpt_icon":0},{"id":"2532857670","title":"港股异动 | 药明康德(02359)再涨超5% 一季度净利增超89% 高盛称公司有空间在下半年提高指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2532857670","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532857670?lang=zh_cn&edition=full","pubTime":"2025-05-02 10:52","pubTimestamp":1746154342,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明康德再涨超5%，截至发稿，涨5.07%，报63.2港元，成交额6004.61万港元。消息面上，药明康德公布2025年第一季度业绩，营业收入约96.55亿元，同比增长20.96%；归属于上市公司股东的净利润约36.72亿元，同比增长89.06%。高盛发表研究报告指，药明康德今年首季财报强劲，管理层维持其2025财年指引，符合该行预期，认为如果未来1至2个季度持续强势，公司有空间在下半年提高指引。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0061475181.USD","IE0002270589.USD","LU0096364046.USD","LU0052750758.USD","LU0106831901.USD","LU2237443382.USD","IE00B19Z3B42.SGD","LU2045819591.USD","LU1868837300.USD","LU2471134879.HKD","LU2237438978.USD","BK4127","LU1868836591.USD","LU1868836757.USD","BK4585","02359","BK4550","LU2237443465.HKD","LU2237443978.SGD","LU2750360997.AUD","IE00BSNM7G36.USD","LU2471134796.USD","LU1997244956.HKD","LU2471134952.CNY","BK0216","BK4516","IE0004086264.USD","LU1046422090.SGD","LU1997245177.USD","603259","BK4533","LU1868836914.USD","LU2237443895.HKD","LU1868837136.USD","LU2237443549.SGD","LU2495084118.USD","IE00B19Z3581.USD","LU1791807156.HKD","IE00BFXG1179.USD","LU2750360641.GBP","BK1583","LU0251142724.SGD","LU2242644610.SGD","LU0708995583.HKD","LU0742534661.SGD","IE0034235188.USD","LU2471134523.USD","BK1576","LU2488822045.USD","BK1141"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746987759941,"stockEarnings":[{"period":"1week","weight":-0.0019},{"period":"1month","weight":0.1524},{"period":"3month","weight":0.0153},{"period":"6month","weight":0.0524},{"period":"1year","weight":0.3344},{"period":"ytd","weight":0.073}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"243419人(较上一季度减少6.80%)","perCapita":"10274股","listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","registeredCapital":"288799万元","survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务。","listedPrice":21.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}